EUVIMEDEUVIMED entdecken
Crossref

Organotin(IV) Azo Hydrazonates as Lysosome‐Targeted Imaging and Anticancer Agents

Sanchita Das, Pratikshya Das Pattanayak, Takahiro Sasamori, Takashi Nakamura, Rupam Dinda iD

Chemistry – An Asian Journal · 2026

DOI: 10.1002/asia.202500912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2026. Verfasst von Sanchita Das und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology, Rourkela, Odisha, India. Hauptthemen laut MEDLINE: Lysosomes, Antineoplastic Agents, Organotin Compounds, Hydrazones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: SERB, CSIR, Govt. of India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metallodrugs with organotin(IV) compounds emerging as a potential alternative to platinum‐based drugs have revolutionized the field of both diagnosis and therapy, offering enhanced anticancer efficacy and bio‐imaging capabilities for targeting intracellular organelles. In this regard, we embarked on an effort to explore the theranostic potential of a new class of azo hydrazone‐based organotin(IV) complexes [ Sn IV L 1–4 (Ph) 2 ] ( 1 – 4 ). The speciation studies suggested the complexes possess exceptional hydrolytic stability. Moreover, the hydrophobic nature of complexes, as determined through partition coefficient measurements, allows their efficient cellular penetration. The cytotoxic potential of 1 – 4 was evaluated against A549, HT–29, and NIH–3T3 cell lines, revealing that 3 was the most toxic among the series, with an IC 50 of 7.8 ± 0.2 µM against A549. Further in‐depth mechanistic studies revealed that they preferentially accumulate in the lysosome, damage lysosomal membrane potential, and upregulate intracellular reactive oxygen species (ROS), leading to apoptotic‐mediated cancer cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesAntineoplastic AgentsOrganotin CompoundsHydrazonesAzo CompoundsHumansAnimalsMiceReactive Oxygen SpeciesDrug Screening Assays, AntitumorApoptosisNIH 3T3 CellsCell ProliferationMolecular StructureCell Line, Tumor

Stichwörter der Autor:innen

anticancerazo‐hydrazonelysosome targetingorganotin(IV)theranostics

Substanzen

Antineoplastic AgentsOrganotin CompoundsReactive Oxygen SpeciesHydrazonesAzo Compounds

Autor:innen und Institutionen

  • Department of Chemistry, National Institute of Technology, Rourkela, Odisha, India.
  • Institute of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.

ORCID-Profile: Rupam Dinda

Förderung

  • SERB
  • CSIR, Govt. of India
  • Science and Engineering Research Board

Zitieren

APA

Das, S., Pattanayak, P. D., Sasamori, T., Nakamura, T., & Dinda, R. (2026). Organotin(IV) Azo Hydrazonates as Lysosome‐Targeted Imaging and Anticancer Agents. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202500912

Vancouver

Das S, Pattanayak PD, Sasamori T, Nakamura T, Dinda R. Organotin(IV) Azo Hydrazonates as Lysosome‐Targeted Imaging and Anticancer Agents. Chemistry – An Asian Journal. 2026. doi:10.1002/asia.202500912

BibTeX
@article{Das2026,
  author = {Das, Sanchita and Pattanayak, Pratikshya Das and Sasamori, Takahiro and Nakamura, Takashi and Dinda, Rupam},
  title = {Organotin(IV) Azo Hydrazonates as Lysosome‐Targeted Imaging and Anticancer Agents},
  journal = {Chemistry – An Asian Journal},
  year = {2026},
  doi = {10.1002/asia.202500912}
}
Kostenlos starten →